Triazolyl Ru(II), Os(II), and Ir(III) complexes as potential HIV-1 entry inhibitors
Background: The human immunodeficiency virus (HIV) is the cause of the acquired immunodeficiency syndrome (AIDS). AIDS is fatal if not treated appropriately. Although there are treatment options for the infection, there are many problems associated with it, including non-compliance to prescribed tre...
| Main Author: | |
|---|---|
| Other Authors: | |
| Language: | en |
| Published: |
University of Pretoria
2021
|
| Subjects: | |
| Online Access: | http://hdl.handle.net/2263/78344 |